PAREXEL introduces next generation Perceptive MyTrials Analytics solution

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched the next generation of its Perceptive MyTrials® platform with advanced analytics capabilities. With the Perceptive MyTrials Analytics solution, clinical trial sponsors can now use a mobile-enabled, single entry-point to access predictive data analytics for multiple studies simultaneously. The solution offers real-time and aggregated analytics allowing sponsors and PAREXEL® clinical research professionals to detect key signals and trends. The Perceptive MyTrials Analytics solution also offers cross-sponsor viewing options for clients who need to evaluate data from multiple sponsors.

"As clinical studies become more complex, there is a growing need for real-time and standardized data and analytics from multiple studies," said Xavier Flinois, President, PAREXEL Informatics. "Using the enhanced tools available with the Perceptive MyTrials Analytics solution, our clients can visualize trends across studies, garner reliable intelligence, and confidently make data-driven business decisions. This information will ultimately help reduce risk, increase clinical trial efficiency, and speed time to market for our clients and for patients."

Developed by PAREXEL Informatics, the Perceptive MyTrials® platform provides an integrated suite of applications for managing clinical trials. Perceptive MyTrials Analytics offers enhanced analytics capabilities and cross-study business intelligence from within the Perceptive MyTrials platform.

Flinois added, "At PAREXEL, our mission is to bring science to the real world by simplifying a client's journey at every step. Perceptive MyTrials Analytics is another example of the integrated solutions we are developing that incorporate optimized study management processes that leverage mobile and analytics as part of our broader 'SMAC' [social media, mobile, analytics, and cloud] technology approach."

Perceptive MyTrials® Analytics is available directly as part of PAREXEL clinical research services or via the Perceptive® Partner Program.

Source:

PAREXEL International Corporation

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Parexel. (2019, June 17). PAREXEL introduces next generation Perceptive MyTrials Analytics solution. News-Medical. Retrieved on September 17, 2021 from https://www.news-medical.net/news/20150721/PAREXEL-introduces-next-generation-Perceptive-MyTrials-Analytics-solution.aspx.

  • MLA

    Parexel. "PAREXEL introduces next generation Perceptive MyTrials Analytics solution". News-Medical. 17 September 2021. <https://www.news-medical.net/news/20150721/PAREXEL-introduces-next-generation-Perceptive-MyTrials-Analytics-solution.aspx>.

  • Chicago

    Parexel. "PAREXEL introduces next generation Perceptive MyTrials Analytics solution". News-Medical. https://www.news-medical.net/news/20150721/PAREXEL-introduces-next-generation-Perceptive-MyTrials-Analytics-solution.aspx. (accessed September 17, 2021).

  • Harvard

    Parexel. 2019. PAREXEL introduces next generation Perceptive MyTrials Analytics solution. News-Medical, viewed 17 September 2021, https://www.news-medical.net/news/20150721/PAREXEL-introduces-next-generation-Perceptive-MyTrials-Analytics-solution.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
PAREXEL International launches Perceptive MyTrials Data-Driven Monitoring solution